Knight Therapeutics | GUD - صافي الدخل

سعر السهم
8.49
التغيير اليومي
-0.13 -1.51%
شهريا
12.01%
سنويا
46.89%
Q2 التوقعات
8.51




صافي الدخل تغيير تاريخ
Acasti Pharma USD -938K 2.42M 2025-09
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Alaunos Therapeutics USD -1.16M 108K 2025-09
Aurora Cannabis CAD 1.82M 53.29M 2025-12
Avita Medical AUD -11.62M 1.7M 2025-12
Canopy Growth CAD -62.63M 60.99M 2025-12
Cronos Group USD 13.75M 15.57M 2026-03
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Ionis Pharmaceuticals USD -93M 136M 2026-03
IQVIA Holdings USD 274M 240M 2026-03
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Moderna USD -1.34B 517M 2026-03
Omeros USD -32.23M 23.81M 2024-09
Organigram Holdings CAD 19.97M 57.93M 2025-12
Organon & Co USD -205M 365M 2025-12
Revvity USD 40.72M 57.65M 2026-03
Tectonic Therapeutic USD -19.23M 186K 2025-12
Tilray USD -44.93M 44.61M 2025-09
Viatris USD 176.4M 516.5M 2026-03
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12